"eccmid 2019" - Google News
[unable to retrieve full-text content]
ASPECT-NP: Randomized, Double-Blind, Phase III Trial Comparing Efficacy & Safety of Ceftolozane/Tazobactam vs Meropenem in Ventilated Nosocomial Pneumonia MedicalResearch.com
Comments
Post a Comment